Valneva SE Pref. Stock Euronext Paris
Stocks
VLAP
FR0011472943
Biotechnology & Medical Research
OTC Markets Traded|
Real-time
Euronext Paris
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | - |
| Market Cap | 572M 664M 536M 491M 916M 62.8B 923M 6.35B 2.47B 32.09B 2.49B 2.44B 103B | P/E 2026 * |
-6.92x | P/E 2027 * | 10.9x |
|---|---|---|---|---|---|
| Enterprise Value | 705M 820M 662M 606M 1.13B 77.49B 1.14B 7.83B 3.05B 39.6B 3.08B 3.01B 128B | EV / Sales 2026 * |
4.67x | EV / Sales 2027 * | 2.24x |
| Free-Float |
97.36% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Valneva SE Pref.
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 62 | - | |
Peter Buhler
DFI | Director of Finance/CFO | 56 | 29/07/2021 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 20/12/2023 | |
James Sulat
BRD | Director/Board Member | 75 | 07/03/2013 |
| Chairman | 65 | 20/12/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 664M | |
| -1.46% | -1.71% | -0.76% | +15.85% | 50.35B | |
| +0.78% | -4.65% | +430.22% | +501.63% | 45.2B | |
| +2.95% | +3.52% | +47.12% | +21.08% | 44.71B | |
| +0.25% | -2.63% | +7.86% | +73.60% | 41.24B | |
| +0.43% | -2.20% | +14.55% | +49.08% | 33.08B | |
| +1.43% | +8.73% | - | - | 17.81B | |
| +0.06% | -2.97% | +23.31% | +116.96% | 16.56B | |
| -0.68% | +0.83% | +16.22% | +28.41% | 14.82B | |
| +0.54% | -1.03% | +80.71% | +39.94% | 14B | |
| Average | +0.43% | -0.15% | +77.40% | +105.82% | 30.86B | |
| Weighted average by Cap. | +0.51% | -0.64% | +92.61% | +123.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 151M 176M 142M 130M 242M 16.59B 244M 1.68B 653M 8.48B 659M 645M 27.31B | 283M 329M 266M 243M 454M 31.13B 458M 3.15B 1.23B 15.91B 1.24B 1.21B 51.24B |
| Net income | -81.11M -94.28M -76.12M -69.64M -130M -8.91B -131M -900M -351M -4.55B -354M -346M -14.67B | 53.07M 61.68M 49.8M 45.57M 85.05M 5.83B 85.72M 589M 229M 2.98B 232M 227M 9.6B |
| Net Debt | 134M 155M 125M 115M 214M 14.69B 216M 1.48B 578M 7.51B 584M 571M 24.18B | 62.48M 72.61M 58.63M 53.64M 100M 6.86B 101M 694M 270M 3.51B 273M 267M 11.3B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VLA Stock
- VLAP Stock
Select your edition
All financial news and data tailored to specific country editions
